Comparison of Clinical Trial Changes in Primary Outcome and Reported Intervention Effect Size Between Trial Registration and Publication

被引:35
|
作者
Chen, Tao [2 ]
Li, Chao [1 ,2 ]
Qin, Rui [3 ]
Wang, Yang [4 ,5 ]
Yu, Dahai [6 ]
Dodd, James [2 ]
Wang, Duolao [2 ]
Cornelius, Victoria [7 ]
机构
[1] Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr, Dept Epidemiol & Hlth Stat, Xian 710061, Peoples R China
[2] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Trop Clin Trials Unit, Liverpool L3 5QA, Merseyside, England
[3] Jiangsu Prov Hosp Integrat Chinese & Western Med, Dept Hlth Educ, Nanjing, Jiangsu, Peoples R China
[4] Peking Union Med Coll, Med Res & Biometr Ctr, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Beijing, Peoples R China
[6] Keele Univ, Arthrit Res UK Primary Care Ctr, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England
[7] Imperial Coll London, Sch Publ Hlth, Imperial Clin Trials Unit, London, England
关键词
RANDOMIZED CONTROLLED-TRIALS; PUBLISHED PRIMARY OUTCOMES; END-POINTS; CONCLUSIONS; QUALITY;
D O I
10.1001/jamanetworkopen.2019.7242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Primary outcome change could threaten the validity of a clinical trial; however, evidence about the consequences on the reported intervention effect size is unclear. OBJECTIVES To examine the status of randomized clinical trials whose primary outcome changed between trial registration and publication and to quantify the association of this change with the reported intervention effect size. DESIGN, SETTING, AND PARTICIPANTS In this cross-sectional study on the primary report of randomized clinical trials with clear prospectively registered primary outcomes, PubMed and Embase were searched for articles published between January 1, 2011, and December 31, 2015. The search was conducted in January 2016, identifying randomized clinical trials and the combination of keywords and text words related to registry. MAIN OUTCOMES AND MEASURES Based on the developed approach, trials were classified as having primary outcome change when there was a major discrepancy between the registered and published primary outcomes. Intervention effect was estimated or recalculated using the odds ratio (OR) for each comparison. Each component OR is structured so that an OR is less than 1 if the intervention group has a more favorable result than the control group. The ratio of ORs (ROR), which is the summary OR for trials with primary outcome change divided by those without, and its 95% CI were calculated, with a value less than 1 indicating a larger reported intervention effect size in trials with primary outcome change than those without. RESULTS Among 29 749 searched articles (28 810 MEDLINE and 939 Embase), 1488 articles were randomly selected for review. Of 389 trials with clear primary outcomes prospectively described in the registry (416 outcomes reported), 33.4% (130 of 389) of trials had at least 1 primary outcome change. Most (66 of 130) of the changes were either not reporting or omitting the primary outcome. In total, 338 trials (365 outcomes and 487 comparisons) were available for quantitative analysis on the reported intervention effect size bias assessment. Compared with those without primary outcome change, trials with primary outcome change showed a 16% (pooled ROR, 0.84; 95% CI, 0.73-0.96) larger reported intervention effect size. The result persisted after adjustment for potential confounders (ROR, 0.81; 95% CI, 0.71-0.93) and other sensitivity and subgroup analyses. CONCLUSIONS AND RELEVANCE Results of this study suggest that inconsistencies between registered and published primary outcomes of clinical trials are common, and trials with primary outcome change are likely to have a larger intervention effect than those without.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Changed Primary Outcome Between Trial Registration and Publication
    Kleinman, Robert A.
    Ostacher, Michael J.
    JAMA INTERNAL MEDICINE, 2020, 180 (11) : 1550 - 1551
  • [2] Changed Primary Outcome Between Trial Registration and Publication Reply
    Anton, Raymond F.
    Hoffman, Michaela
    JAMA INTERNAL MEDICINE, 2020, 180 (11) : 1551 - 1552
  • [3] Reporting of Clinical Trials: Publication, Authorship, and Trial Registration
    Bonita, Raphael E.
    Adams, Suzanne
    Whellan, David J.
    HEART FAILURE CLINICS, 2011, 7 (04) : 561 - +
  • [4] Clinical Trial Registration and Publication of Randomized Controlled Trials
    Lockshin, Michael D.
    Katz, Patricia P.
    Yelin, Edward H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (06): : 517 - 518
  • [5] Selective registration of non-primary endpoints in randomized clinical trials in oncology: a comparison of endpoint reporting between clinical trial protocols and US national clinical trial registration
    Serpas, V.
    Halperin, D.
    Raghav, K.
    Overman, M. J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Clarification of Clinical Trial Registration and Reported Study Outcomes
    Resick, Patrick A.
    Wachen, Jennifer Schuster
    Peterson, Alan L.
    JAMA PSYCHIATRY, 2017, 74 (06) : 654 - 655
  • [7] Clinical Trial Registration: A Mandatory Requirement for Publication in the Red Journal
    Palma, David A.
    Zietman, Anthony
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 91 (04): : 685 - 686
  • [8] Appropriate Clinical Trial Registration Is the Key to Transparent Reporting and Publication
    Fujii, Satoru
    Bainbridge, Daniel
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (06) : 1578 - 1580
  • [9] Clinical trial registration and publication in acupuncture studies: a systematic review
    Matsuura, Yuto
    Welch, Naomi Takazawa
    Sakai, Tomomi
    Tsutani, Kiichiro
    INTEGRATIVE MEDICINE RESEARCH, 2020, 9 (01) : 56 - 61
  • [10] Association of the FDA Amendment Act with trial registration, publication, and outcome reporting
    Phillips, Adam T.
    Desai, Nihar R.
    Krumholz, Harlan M.
    Zou, Constance X.
    Miller, Jennifer E.
    Ross, Joseph S.
    TRIALS, 2017, 18